Price
Target price
€68.54
€68.54
-2.150%
-1.56
-2.150%
€77.09
25.02.26 / Tradegate
WKN: A2ACMZ / Symbol: IONS / Name: Ionis Pharmaceuticals / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Ionis Pharmaceuticals Inc. Stock
We can see a decrease in the price for Ionis Pharmaceuticals Inc.. Compared to yesterday it has lost -€1.560 (-2.150%).
With 48 Buy predictions and 1 Sell predictions Ionis Pharmaceuticals Inc. is one of the favorites of our community.
As a result the target price of 77 € shows a slightly positive potential of 12.34% compared to the current price of 68.54 € for Ionis Pharmaceuticals Inc..
For the coming years our community has positive and negative things to say abot the Ionis Pharmaceuticals Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Ionis Pharmaceuticals Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ionis Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | -2.150% | -1.777% | 0.943% | 124.648% | 0.853% | 98.035% | 56.003% |
| Iovance Biotherapeutics Inc. | 1.470% | 39.741% | 44.943% | -36.413% | 36.235% | -51.347% | -89.243% |
| United Therapeutics | 12.070% | 11.714% | 14.700% | 33.715% | 6.459% | 92.103% | 224.929% |
| Neurocrine Bioscience | -0.810% | 3.013% | -3.559% | 0.725% | -8.972% | 14.383% | 22.330% |
Comments
Ionis Pharmaceuticals (IONS) had its "buy" rating reaffirmed by Needham & Company LLC.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $95.00 price target on the stock.
Show more
Ratings data for IONS provided by MarketBeat